Samsung Leejung Women's Clinic Doctor's Column
Obstetrics & Gynecology Column

Genoo Test and NIPT: When Can You Have Them and How Do They Differ?

The purpose of the Genoo test and of NIPT, and how the two differ by week of pregnancy.

Published 2026-10-28 Updated 2026-10-28 Reviewed by Hyejeong Lee, Medical Director · Obstetrics & Gynecology Specialist

The Genoo test and NIPT come up often as tests that give news about the baby in early pregnancy from a blood draw alone. The names are similar, but the two tests check different things and can be taken at different times. The Genoo test identifies the baby's sex, while NIPT screens for the risk of chromosomal abnormalities, so one cannot replace the other.

Once you are clear about what you want to know, it becomes much clearer which test to have and when. This article sets out when you can start each test, what each one checks, and what is useful to know before having them.

01

When can you start the Genoo test and NIPT?

Key point
The Genoo test can be done by blood draw from around week 6 of pregnancy, while NIPT is carried out after week 10, once the proportion of fetal DNA has stabilised. The time when the sex can be confirmed directly on ultrasound comes later, at around week 16.

Fragments of the baby's DNA released from the placenta circulate in the mother's blood, and their proportion rises as the pregnancy progresses. The point at which this proportion is high enough sets the earliest week for each test, so even though the blood is drawn in the same way, the starting times differ.

If you want to know the sex early, the schedule is built around the Genoo test; if you also want to look at the risk of chromosomal abnormalities, it is built around NIPT, which is carried out once the proportion of fetal DNA has stabilised. Keeping the timings below in mind helps when planning clinic visits.

  • Genoo test — a blood draw is possible from around week 6 of pregnancy, and the sex is identified by whether a Y chromosome is present
  • NIPT — carried out from week 10 of pregnancy onwards, once the proportion of fetal DNA has stabilised
  • Sex on ultrasound — checked visually at around week 16 of pregnancy, when the shape of the genitals becomes clear
Anatomy illustration related to Genoo Test and NIPT: When Can You Have Them and How Do They Differ?
02

Do the Genoo test and NIPT check different things?

Key point
The Genoo test identifies the baby's sex solely from whether a Y chromosome is present, while NIPT looks at the risk of chromosomal abnormalities, including Down syndrome. The detection rate of NIPT for Down syndrome is reported at around 99%, so the purposes themselves differ.

Because the names are similar and the blood draw is the same, it is easy to assume the two tests serve the same purpose, but the questions they answer are entirely different. The Genoo test looks at a single sex chromosome and reads the result as boy or girl, whereas NIPT is a screening test that looks broadly at whether there are numerical abnormalities in several chromosomes and at the level of risk.

Both tests work on the same principle of analysing fragments of fetal DNA in the mother's blood, but what they read from it differs. Having one does not make the other unnecessary, and it is more accurate to understand sex identification and chromosomal screening as tests carried out for separate purposes.

  • Genoo test result — read as a boy if a Y chromosome is detected, and as a girl if it is not
  • What NIPT checks — the risk of major chromosomal abnormalities, including Down syndrome
  • Detection rate — the detection rate of NIPT for Down syndrome is reported at around 99%
03

What is useful to know before having the Genoo test or NIPT?

Key point
Because NIPT is a screening test that screens for risk, a high-risk result does not lead straight to a conclusion; it goes through further testing for final confirmation. If the proportion of fetal DNA is low, a repeat blood draw may be needed, and with twins, a consultation beforehand is needed.

NIPT is a screening test designed to identify the possibility of chromosomal abnormalities in advance, so a high-risk result does not confirm a diagnosis on the spot. A final conclusion is reached only after a separate confirmation step, such as amniocentesis.

As a blood test, it can also be affected by variables. If the proportion of fetal DNA is not sufficient, the result cannot be read and the blood has to be drawn again. With twins, the genetic material is mixed, which makes interpretation more difficult, so it is safer to discuss this with the medical team before the test.

  • Complementary tests — choose the Genoo test if you want to know the sex, and NIPT if you want to know the risk of chromosomal abnormalities
  • Possible retest — if the proportion of fetal DNA is low, no result may be produced and the blood may need to be drawn again
  • With twins — interpreting the genetic material is more difficult, so this should be discussed with the medical team before the test
Hyejeong Lee, Medical Director
Doctor's view

How the doctor decides

Hyejeong Lee, Medical Director · Obstetrics & Gynecology Specialist

I do not treat sex and chromosomal risk as the same test

I do not describe the Genoo test and NIPT as two names for one test. The two share only the method of a blood draw, and their purposes are entirely different, so I first ask whether what the mother wants to know is the sex or the risk of chromosomal abnormalities, and then recommend the test that fits.

I check the timing of the result first

I start by checking how many weeks pregnant the mother is. A blood draw for the Genoo test is possible from around week 6 of pregnancy, but NIPT can give a reliable result only after week 10, once the proportion of fetal DNA has stabilised, so I do not rush to recommend NIPT when the pregnancy is still early.

I do not draw conclusions from a high-risk NIPT result on the spot

A high-risk finding on NIPT does not mean I conclude straight away that an abnormality is confirmed. Because NIPT is a screening test that screens for risk, I explain further confirmation steps such as amniocentesis, and I give my final explanation only after seeing those results.

I explain repeat blood draws and twin pregnancies in advance

Before the test, I explain that a repeat blood draw may be needed if the proportion of fetal DNA is low, and that interpretation can be more difficult with twins. I believe it helps the mother more to know this beforehand than to hear unexpected news later.

Summary

In summary

The Genoo test and NIPT are easy to confuse because their names are similar, but they check different things and can be taken at different times. If you want to know the sex, the Genoo test is the one to consider; if you also want to look at the risk of chromosomal abnormalities, consider NIPT. It is worth remembering that even a high-risk finding still leaves further confirmation steps. Asking about anything you are unsure of during your appointment is the most accurate way to get an answer.

FAQ

Frequently asked questions

QDo I need to have both the Genoo test and NIPT?
A

The two tests give different information, so the choice depends on what you want to know. If you only want to know the sex, the Genoo test is enough, but if you also want to check the risk of chromosomal abnormalities, NIPT has to be taken separately.

QWhen can I start the Genoo test?
A

A blood draw for the Genoo test is possible from around week 6 of pregnancy. The exact timing can vary with the mother's condition, however, so it is advisable to confirm it through a consultation during your appointment.

QDoes a high-risk NIPT result mean there is definitely an abnormality?
A

No. NIPT is a screening test that screens for risk, so even with a high-risk finding, the final judgement is made after further confirmation steps such as amniocentesis.

Hyejeong Lee, Medical Director
Medical review
Hyejeong Lee, Medical Director · Obstetrics & Gynecology Specialist
This content is general medical information and may not apply to every individual. Diagnosis and treatment are decided through a consultation.